SCHEDULE 13G/A: Roxy Capital Corp Amends Stake in Firefly Neuroscience, Inc., Reports 3.65% Beneficial Ownership

Roxy Capital Corp has filed an amended Schedule 13G, disclosing a 3.65% beneficial ownership stake in Firefly Neuroscience, Inc.'s common stock.

Summary

• Roxy Capital Corp filed an Amendment No. 1 to Schedule 13G with the SEC.
• The filing reports beneficial ownership of 424,689 shares of Firefly Neuroscience, Inc. common stock, par value $0.001 per share.
• This ownership represents 3.65% of the class of securities.
• Roxy Capital Corp, a Cayman Islands entity, holds sole voting power and sole dispositive power over all 424,689 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a standard Schedule 13G filing disclosing beneficial ownership, which is a factual regulatory update and does not inherently convey positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

The document, a Schedule 13G filing, does not contain any forward-looking statements or guidance regarding the issuer's future outlook.

Management Comments

• Roxy Capital Corp Director Eric Lazer certified that, to the best of his knowledge and belief, the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

Industry Context

This Schedule 13G filing is a routine disclosure of beneficial ownership and does not provide specific insights into broader industry trends or competitive dynamics within the neuroscience or biotechnology sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding the ownership structure and the stake held by Roxy Capital Corp.

Key Dates

Keywords

Firefly Neuroscience, Roxy Capital Corp, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership, Equity Stake